More specifically, while central infusion of a GLP-1 receptor antagonist followed by anorexigenic dose of oxytocin eliminated the anorexigenic effect of oxytocin, central infusion of an oxytocin receptor antagonist followed by synthetic GLP-1 ligand does not affect GLP-1-induced anorexia [134]. The gene discussed is OXT; the disease is Anorexia.